Molina Healthcare Sued for Potential Securities Law Violations

A lawsuit has been filed against Molina Healthcare, Inc. and certain of its senior executives for potential violations of federal securities laws. The complaint alleges that the Company misled investors about its earnings growth and ability to mitigate medical cost pressures.

Key Takeaways:

  • Molina Healthcare is a health insurance company that provides managed healthcare services to low-income individuals under Medicaid and Medicare programs.
  • The Company allegedly faced increased medical cost pressures due to increased utilization in all three of its business lines, contradicting its public statements about its earnings growth and ability to mitigate costs.
  • On July 7, 2025, Molina revealed that its Q2 2025 adjusted earnings were below its prior expectations, causing the stock price to decline.
  • On July 23, 2025, Molina revealed that it expected its full year 2025 adjusted earnings to be no less than $19.00 per diluted share, citing a "challenging medical cost trend environment."
  • The price of Molina stock fell $32.03 per share, or 16.8%, from $190.25 per share on July 23, 2025, to $158.22 per share on July 24, 2025.
  • Investors who purchased Molina securities between January 21, 2025, and July 23, 2025, may have legal options and are encouraged to submit their information to the law firm representing the plaintiffs.
  • The law firm, Bleichmar Fonti & Auld LLP, has a history of success in securities class actions and shareholder litigation, including recovering over $900 million in value from Tesla, Inc.'s Board of Directors and $420 million from Teva Pharmaceutical Ind. Ltd.

Statistics:

  • Molina Healthcare's Q2 2025 adjusted earnings were approximately $5.50 per share, below its prior expectations.
  • The Company cut guidance for expected adjusted earnings per share by 10.2% at the midpoint to a range of $21.50 to $22.50 per share.
  • The price of Molina stock fell $32.03 per share, or 16.8%, on July 24, 2025.
  • The law firm recovered over $900 million in value from Tesla, Inc.'s Board of Directors and $420 million from Teva Pharmaceutical Ind. Ltd.

Sources:

  • "Molina Healthcare Sued by NYSE: MOH Shareholders After Judge Hands Over $32 Million to Artificial Intelligence Firm after Filing a Securities Class Action Lawsuit." GlobeNewswire, 16 Oct. 2025.
  • Hindlemann v. Molina Healthcare, Inc., et al., No. 25-cv-9461 (U.S. District Court for the Central District of California).
  • Bleichmar Fonti & Auld LLP. "Notable Successes."